期刊文献+

进展性脑梗死的危险因素及临床研究 被引量:15

Clinical study on the risk factors of progressive cerebral infarction
下载PDF
导出
摘要 目的探讨进展性脑梗死的危险因素及临床特点。方法对进展性脑梗死组(68例)和非进展脑梗死组(92例)进行统计分析比较,一般情况、既往史、血常规、凝血全项、血脂血糖、颈动脉彩超、同型半胱氨酸(Hcy)、纤维蛋白原(Fb)、C-反应蛋白的差异性。结果进展组的高血压、糖尿病发生率均高于非进展组(P<0.01),C-反应蛋白、白细胞计数、血浆Hcy和Fb均有统计学意义(P<0.01)。进展组溃疡斑10例,软斑34例,明显高于非进展组。结论高血压、糖尿病、感染、高同型半胱氨酸血症(Hhcy)、动脉硬化斑块可能是进展性脑梗死的危险因素。 Objective To investigate the risk factors and the clinical characteristics of progressive cerebral infarction. Methods The patients with cerebral infarction were randomized into two groups: progressive cerebral infarction group (n=68) and non-progressive cerebral infarction group(n= 92). The patients' material of past history, blood test, blood clotting set, blood lipid and blood sugar, carotid artery ultrasound (CAU), Hcy, Fb, CRP in the two groups were compared. Results There was a higher incidence rate of hypertension and diabetes in the progressive cerebral infarction group (P〈0.01). There were significant differences in the levels of CRP, white blood cell count, Hcy, Fb between the two groups (P〈0.01). As the carotid artery arteriosclerotic plaques, there were 10 cases with ulcer plaque and 34 cases with soft plaque in the progressive cerebral infarction group, which was significantly higher than that of no,progressive cerebral infarction group. Conclusion Hypertension, diabetes, infection, Hhcy and carotid artery arteriosclerotic plaques may be the risk factors of progressive cerebral infarction.
出处 《中国实用神经疾病杂志》 2010年第24期32-34,共3页 Chinese Journal of Practical Nervous Diseases
关键词 进展性脑梗死 危险因素 临床特点 Progressive cerebral infarction Risk factor Clinical characteristics
  • 相关文献

参考文献10

  • 1Davalos MD, Tom MD, Lweins MS, et al. Neurological deterioration in acute ischemic stroke potential predictors and associated factors in the European cooperative acute stroke study (ECASS) [J]. Stroke, 1999,12 : 2 631.
  • 2贺庆红,李治安,章新新,张志诚,马会堂.应用彩色多普勒超声初步探讨脑梗塞与颈动脉粥样硬化病变的关系[J].中国医学影像技术,2003,19(12):1679-1681. 被引量:59
  • 3Thanvi B, Treadwell S, Robinson T. Early neurological deterioration in acute ischaemic stroke: predictors, mechanisms and management[J]. Postgrad Med J, 2008,84 (994) : 412-417.
  • 4范乐明.动脉粥样硬化炎症机制的再认识[J].中国动脉硬化杂志,2005,13(3):249-253. 被引量:73
  • 5Gardre E, Lassen NA. Apoplexy with rapidly deteriorating symptoms stroke in progression: Hemodynamic and clinical aspect [J]. Ugeskr Laeger,1995,157(30):4 234.
  • 6Fortin LJ,GenestJ. Measurement of honocysteine in the prediction of arteriosclerosis[J]. Clin Biochem, 1995,28:1 552-1 621.
  • 7Suhara T, Fukuo K, yasuda O, et al. Homocysteine enhances endothelial apoptosis via ypregulation of Fas-mediated pathways[J], hypertension,2004,43(6) :1 208-1 213.
  • 8卜瑞芳,邓振霞,沈泓,许岚,吴懿玲,蒋艳敏,华嘉临,张稷.血浆同型半胱氨酸水平与2型糖尿病合并脑梗死的关系[J].中华内分泌代谢杂志,2004,20(5):444-445. 被引量:38
  • 9Sauls DL,Wolberg AS, Hoffman M. Elevated plasma homoeysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hypehomocysteinemia[J].Thromb Haemost, 2003,1 (2) : 300-306.
  • 10Kitamura A,Iso H,Imano H,et al. Carotid intima-media thickness and plaque characteristics as risk factor for stroke in Japanese elderly men[J]. Stroke,2004,35(12) :2 788-2 794.

二级参考文献68

  • 1Roes R. Atherosclemsis - an inflammatory disease. N Engl J Med, 1999,340:115-126.
  • 2Cathcart MK. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages contributions to atherosclerosis.Arterioscler Thromb Vasc Biol, 2004, 24(1): 23-28.
  • 3Rama Natarajan, Nadler JL.Lipid Inflammatory Mediators in Diabetic Vascular Disease.Arterioscler Thromb Vasc Biol,2004,24:1542-548.
  • 4Hosono M, de Boer OJ, van der Wal AC, van der Loos CM, Teeling P, Piek JJ,et al.Increased expression of T cell activation markers (CD25,CD26,CD40Land CD69)in atherectomy specimens of patients with unstable angina and acute myocardial infarction.Atherosclerosis,2003,168:73-80.
  • 5Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med, 2002, 347(1): 5-12.
  • 6Libby P. Inflammation in atherosclemsis. Nature,2002,420:868-874.
  • 7Miller YI,Chang MK, Binder CJ, Shaw PX, Witztum JL. Oxidized low density lipoprotein and innate immune receptors. Curr Opin Lipidol, 2003, 14: 437-445.
  • 8Maggi E, Perani G, Falaschi F, Frattoni A, Martignoni A, Finardi G, et al.Autoantibodies against oxidized low density lipoproteins in patients with coronary disease. Presse Med, 1994, 23: 1158-162.
  • 9Mehta JL, Saldeen TG, Rand K. Interactive role of infection, inflammation and traditional risk factors in atherosclerosos and coronary artery disease. J Am Coll Cardiol, 1998, 31:1217-225.
  • 10Hofman A. Lipopotein-associated phospholipase A2 is associated with risk of coronary heart disesse and stroke. The Rotterdam study. Presented at the European Society of Cardiology Congress 2004. Munich, Germarry, 30 August 2004.

共引文献167

同被引文献59

引证文献15

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部